Shares of Zoetis Inc (NYSE:ZTS) ended Friday session in green amid volatile trading. The shares closed up +0.19 points or 0.37% at $51.26 with 2.23 million shares getting traded. Post opening the session at $51.34, the shares hit an intraday low of $51.08 and an intraday high of $51.40 and the price vacillated in this range throughout the day. The company has a market cap of $25.38 billion and the numbers of outstanding shares have been calculated to be 495.39 million shares.
Zoetis Inc (ZTS) on August 22, 2016 announced that Glenn David, Senior Vice President of Finance Operations, has been named Executive Vice President and Chief Financial Officer (CFO), and will assume responsibility for the oversight of the company’s financial management, planning and global operations, effective immediately. As CFO, David will report directly to Chief Executive Officer Juan Ramón Alaix and become part of the Zoetis Executive Team. David will succeed Executive Vice President and Chief Financial Officer Paul Herendeen, who has resigned effective August 18, 2016, to accept the position of CFO at another public company.
“Glenn has been an accomplished financial and strategic leader for Zoetis and a trusted partner to me and the entire executive team since our IPO,” said Chief Executive Officer Juan Ramón Alaix. “Glenn’s strong financial acumen, deep understanding of our company’s business operations and ability to partner with our business leaders to improve overall company performance, make him the clear successor for this important position. With this natural transition of executive responsibility to such a high caliber executive, the Board and I are confident we have ensured continued focus on delivering shareholder value.”
“We thank Paul for his contributions to our company over the past two years. Paul leaves Zoetis a stronger company, better positioned with investors and set to deliver long-term, sustainable shareholder value,” said Alaix.
Shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) ended Friday session in red amid volatile trading. The shares closed down -0.58 points or -1.93% at $29.46 with 1.60 million shares getting traded. Post opening the session at $30.11, the shares hit an intraday low of $29.38 and an intraday high of $30.50 and the price vacillated in this range throughout the day. The company has a market cap of $3.61 billion and the numbers of outstanding shares have been calculated to be 120.92 million shares.
Ionis Pharmaceuticals Inc (IONS) announced that management will present a company overview at the following investor conferences:
2016 Wells Fargo Healthcare Conference on Thursday, September 8, 2016 in Boston, MA
2016 Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 in New York, NY
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company’s website. Please check www.ionispharma.com for the latest information.
A live webcast of the presentations will be available on the “Investors & Media” section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.